Robert Dickey IV

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Philadelphia, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Robert Dickey
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Robert Dickey IV

Form 4 holding Director, INDEPENDENT DIRECTOR

AngioGenex, Inc.

Security class
Stock Option
Shares / value
850,000
Estimated value
Report date
02 Sep 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Robert Dickey IV

3

Invitae Corp

Report period
14 Aug 2023
Transactions
0
Transaction value
$0
Accepted by SEC
17 Aug 2023, 19:40
Role
Interim Chief Financial Officer Exhibit List: Exhibit 24 - Power of Attorney
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .